LASE Corp 8-K, filed Feb 24, 2023
LASE Corp. (LASE)
About this 8-K
LASE Corp filed this 8-K on February 24, 2023, reporting on events of February 17, 2023.
Items reported
- Item 3.01: Delisting notice or listing transfer
- Item 9.01: Financial statements and exhibits
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM
CURRENT REPORT
Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934
Date of Report (Date of earliest event reported):
(Exact name of registrant as specified in its charter) |
|
| |||
(State of other jurisdiction of incorporation) |
| (Commission File Number) |
| (IRS Employer Identification No.) |
| ||
(Address of principal executive offices) |
| (Zip Code) |
Registrant’s telephone number, including area code: (
_____________________________________________
(Former name or former address, if changed since last report.)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
Title of each class | Trading Symbol(s) | Name of each exchange on which registered | ||
Emerging growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing.
On February 17, 2023, the registrant (“Laser Photonics” or the “Company”) received a notice from Nasdaq Listing Qualifications department of the Nasdaq Stock Market LLC ("Nasdaq") stating that the Company no longer complies with Nasdaq’s audit committee requirement under Nasdaq’s Listing Rule 5605 following the resignation of Glenn Peterson from the Company’s board of directors and audit committee effective December 16, 2022. Nasdaq advised Laser Photonics that in accordance with Nasdaq’s Listing Rule 5605(c)(4) the Company has a cure period to regain compliance (i) until the earlier of the Company's next annual shareholders’ meeting or December 16, 2023; or (ii) if the next annual shareholders’ meeting is held before June 14, 2023, then the Company must evidence compliance no later than June 14, 2023 (the “Cure Period”). The Company is currently evaluating candidates for this role.
Item 9.01 Financial Statements and Exhibits.
| Exhibits |
|
|
| 104 Cover Page Interactive Data File (embedded within the Inline XBRL document) |
2 |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
| LASER PHOTONICS CORPORATION | |||
| Date: February 24, 2023 | By: | /s/ Wayne Tupuola | |
|
| Wayne Tupuola | |
President and CEO | |||
3 |